We first examined the expression of BXDC2 in 4 human bladder cancer lines that were known to be AR-negative (i.e., 5637, 647V) or AR-positive (i.e., UMUC3, TCCSUP) [14]. The gene discussed is BRIX1; the disease is urinary bladder cancer.